Aytu BioPharma (AYTU) Insider Trading & Ownership $1.59 +0.04 (+2.58%) (As of 12:07 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Aytu BioPharma (NASDAQ:AYTU) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.77%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$97,201.62Number OfInsiders Selling(Last 3 Years)0 Get AYTU Insider Trade Alerts Want to know when executives and insiders are buying or selling Aytu BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AYTU Insider Buying and Selling by Quarter Ad Behind the MarketsDylan Jovine's #1 Retirement Play for 2024Register: My First LIVE Event in 5 Years! On Tuesday, November 19th, I'm breaking my "no webinars" rule and going LIVE at 8:00pm Eastern. You won't want to miss this event. I'm releasing my No. 1 Retirement Play in 2024. It has nothing to do with regular stocks, options, cryptos or any investment fads.Click here now to register for "Our #1 Takeover Target for November" event. Aytu BioPharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/16/2023Greg PyszczymukaInsiderBuy12,000$1.87$22,440.00 6/14/2023Joshua R DisbrowCEOBuy14,000$1.86$26,040.00 12/19/2022Greg PyszczymukaInsiderBuy100,000$0.24$24,000.00 12/19/2022Joshua R DisbrowCEOBuy112,371$0.22$24,721.62 (Data available from 1/1/2013 forward) AYTU Insider Trading Activity - Frequently Asked Questions Who is on Aytu BioPharma's Insider Roster? The list of insiders at Aytu BioPharma includes Greg Pyszczymuka, and Joshua R Disbrow. Learn more on insiders at AYTU. What percentage of Aytu BioPharma stock is owned by insiders? 2.77% of Aytu BioPharma stock is owned by insiders. Learn more on AYTU's insider holdings. Which Aytu BioPharma insiders have been buying company stock? The following insiders have purchased AYTU shares in the last 24 months: Greg Pyszczymuka ($46,440.00), and Joshua R Disbrow ($50,761.62). How much insider buying is happening at Aytu BioPharma? Insiders have purchased a total of 238,371 AYTU shares in the last 24 months for a total of $97,201.62 bought. Aytu BioPharma Key ExecutivesMr. Joshua R. Disbrow (Age 49)Chairman & CEO Compensation: $708kMr. Mark K. Oki CPA (Age 55)CFO, Secretary & Treasurer Compensation: $522.84kMs. Victoria CordovaVice President of People & CultureMr. Jarrett T. Disbrow Ph.D. (Age 49)Chief Business Officer & President of Consumer Health Compensation: $355kMr. Russ McMahenSenior Vice President of Research & DevelopmentMr. Ryan J. Selhorn CPA (Age 42)Executive VP of Finance & Business Optimization More Insider Trading Tools from MarketBeat Related Companies VRCA Insider Transactions VTVT Insider Transactions PASG Insider Transactions ELEV Insider Transactions CERO Insider Transactions DRRX Insider Transactions LTRN Insider Transactions CALC Insider Transactions OKYO Insider Transactions LEXX Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:AYTU) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aytu BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aytu BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
